MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$2,832,166
EPS
-$0.54
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Research and development
1,464,655
3,091,390.5*
1,899,251
1,226,954
General and administrative
1,326,891
2,193,765.5*
1,576,577
1,540,910
Total operating expenses
2,791,546
5,285,156
3,475,828
2,767,864
Loss from operations
-2,791,546
-5,285,156*
-3,475,828
-2,767,864
Investment income, net
32,518
44,652.5
46,704
27,305
Interest expense
77,273
-
-
-
Change in fair value of derivative liability
22,187
-
-
-
Total other income (expense), net
-22,568
44,652.5*
46,704
27,305
Net loss
-2,814,114
-5,240,503.5
-3,429,124
-2,740,559
Deemed dividend series a preferred stock
18,052
-
-
-
Net loss available to common share available to common shareholders
-2,832,166
-
-
-
Basic EPS
-0.54
-2.468
-1.16
-2.15
Diluted EPS
-0.54
-2.468
-1.16
-2.15
Basic Average Shares
5,232,625
2,123,344*
2,943,655
1,277,217
Diluted Average Shares
5,232,625
2,123,344*
2,943,655
1,277,217
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss available
to common share...
-$2,832,166
Net loss
-$2,814,114
(-2.68%↓ Y/Y)
Deemed dividend series
a preferred stock
$18,052
Loss from operations
-$2,791,546
(-0.86%↓ Y/Y)
Total other income
(expense), net
-$22,568
(-182.65%↓ Y/Y)
Investment income, net
$32,518
(19.09%↑ Y/Y)
Change in fair value of
derivative liability
$22,187
Total operating
expenses
$2,791,546
(0.86%↑ Y/Y)
Interest expense
$77,273
Research and development
$1,464,655
(19.37%↑ Y/Y)
General and
administrative
$1,326,891
(-13.89%↓ Y/Y)
Buy us a coffee
Imunon, Inc. (IMNN)
Imunon, Inc. (IMNN)